CHRISTINA NAWARA: Open Payments
NPI 1760059174 · TINLEY PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,786 in 112 payments from 36 companies in 2025. Trend: 2023 $95 · 2024 $888 · 2025 $2,786
Food & beverage: $2,379Education: $406
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $300 |
| Celgene Corporation | 7 | $276 |
| Novartis Pharmaceuticals Corporation | 16 | $235 |
| AstraZeneca Pharmaceuticals LP | 10 | $222 |
| Daiichi Sankyo Inc. | 5 | $181 |
| TerSera Therapeutics LLC | 5 | $167 |
| Merck Sharp & Dohme LLC | 6 | $140 |
| Janssen Biotech, Inc. | 3 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $109 |
| Genentech USA, Inc. | 4 | $96 |
Products named: REBLOZYL, KISQALI, Enhertu, Xermelo, KEYTRUDA, RYBREVANT, CALQUENCE, Xtandi.
Industry payments across IL — which companies pay providers there.
